Our PartnersOver WordPress
Leiden University
Medical Center
Academic Hospital – Leiden, NL
LUMC is a modern university medical center for research, education and patient care with a high-quality profile and a strong scientific orientation. The LUMC has set Regenerative Medicine as one of its key focus areas.
Centre for Commercialization of Regenerative Medicine
Contract Development and Manufacturing Organisation – Toronto, CA
CCRM is a not-for-profit, public-private consortium supporting the development of foundational technologies that accelerate the commercialization of cell and gene therapies, and regenerative medicine technologies.
Starfish Innovations
Commercialization partner – Leiden, NL
Starfish Innovations brings new medicines closer to the patient by commercialising innovative regenerative medicine therapies, diagnostics and technologies from leading European universities, Institutes and other partners to accelerate breakthroughs in regenerative medicine across a broad range of diseases.
Leiden University
Public research university – Leiden, NL
The university is founded in 1575 and has seven academic faculties and over fifty subject departments while housing more than 40 national and international research institutes.
CHDR
Clinical research organisation – Leiden, NL
The Centre for Human Drug Research (CHDR) is an independent institute that specialises in cutting-edge early-stage clinical drug research.
RegMed XB
Public private partnership – The Netherlands & Belgium
RegMed XB is a virtual institute of Dutch and Belgian public (universities and governments) and private (health foundations and companies) partners that will work together to develop regenerative medicine solutions to health challenges.
reNEW
Novo Nordisk Foundation Center for Stem Cell Medicine
reNEW is a research consortium based on a apartnership between the University of Copenhagen, Leiden University Medical Center, and the Murdoch Children’s Research Institute.
BIOMÉRIEUX
Multinational diagnostic solutions provider
A world leader in the field of in vitro diagnostics since 1963, bioMérieux’ suite of innovative solutions provides rapid, highly accurate methods to reduce risk, boost operations efficiency, facilitate regulatory compliance, and empower smarter, data driven decision-making in the field of pharma quality control.
